“…Further demonstrating the utility of gyrification measurements, studies of patient populations have demonstrated differences in gyrification relative to healthy individuals in relation to Alzheimer’s disease (King et al, 2010; Liu et al, 2012), schizophrenia (Cao et al, 2017; Palaniyappan & Liddle, 2012; Palaniyappan et al, 2015), autism (Schaer et al, 2013), and major depression disorder (Cao et al, 2017), among other psychiatric disorders. Within healthy samples, age-related differences in cortical folding structure have also been associated with individual functional differences (e.g., see Lamballais et al, 2020; McDonough & Madan, in press).…”